太极拳运动在高血压患者中的有效性:系统性审查和元分析
Wenxuan Zhang1, Hong Wang1, Zheng Xiong1
1Wushu Academy, Wuhan Institute of Physical Education, Wuhan, Hubei, 430079, PR China.
Current problems in cardiology
|August 29, 2024
概括
太极拳在高血压患者中显著降低了缩血压 (SBP),但没有显著影响缩血压 (DBP). 这种非药理学方法为管理高血压提供了潜在的补充疗法.
科学领域:
- 心脏病学 心脏病学
- 综合医学是一个整体的医学.
- 公共卫生 公共卫生
背景情况:
- 在全球范围内,高血压影响了128亿成年人,在低收入和中等收入国家不成比例.
- 高血压的药物治疗有相关的副作用,需要探索非药物替代品.
- 太极拳是一种潜在的非药物干预,但其降低血压的有效性需要进一步澄清.
研究的目的:
- 系统地审查和元分析太极拳在降低高血压患者的缩血压 (SBP) 和腹缩血压 (DBP) 的有效性.
主要方法:
- 遵守PRISMA指南和PROSPERO注册 (CRD42024496192) 的要求.
- 在2023年12月,在PubMed,科学网络,Embase和Cochrane图书馆数据库中进行全面的文献搜索.
- 包括五项随机对照试验 (568名患者),包括偏差风险评估和随机效应模型元分析.
主要成果:
- 与常规护理相比,太极拳显示了SBP的统计显著减少 (MD = 5.49,95% CI: 3.44至7.54,p = 0.001),具有中等异质性 (I2 = 54%).
- 在太极拳和标准护理之间没有观察到DBP的统计学上显著差异 (MD = 3.18,95%CI:1.89至-4.48,p = 0.31).
- 包括的研究以小样本大小和实质性的异质性为特征.
结论:
- 太极拳在降低高血压患者中SBP水平方面有效.
- 目前的证据不支持太极拳对高血压患者的DBP具有统计学意义的影响.
- 考虑到研究的局限性,可能需要进一步的研究来澄清太极拳对DBP的影响.
相关概念视频
01:18Disorders of the Autonomic Nervous System
589
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
589
01:18Hypertension and Regulation of Blood Pressure
2.0K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K
01:17Antihypertensive Drugs: Action of β1 Blockers
327
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
327
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
404
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404
01:17Increased pulse rate
651
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
651
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
510
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
510